Endothelin Receptor Blocker Reverses Breast Cancer–Induced Cardiac Remodeling

BACKGROUND: Although some cancer therapies have overt and/or subclinical cardiotoxic effects that increase subsequent cardiovascular risk in breast cancer patients, we have recently shown that the breast tumor itself can also induce cardiac hypertrophy through the activation of the endothelin system...

Descripción completa

Detalles Bibliográficos
Autores principales: Maayah, Zaid H., Ferdaoussi, Mourad, Boukouris, Aristeidis E., Takahara, Shingo, Das, Subhash K., Khairy, Mostafa, Mackey, John R., Pituskin, Edith, Sutendra, Gopinath, Paterson, D. Ian, Dyck, Jason R.B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635889/
https://www.ncbi.nlm.nih.gov/pubmed/37969640
http://dx.doi.org/10.1016/j.jaccao.2023.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635889/
https://www.ncbi.nlm.nih.gov/pubmed/37969640
http://dx.doi.org/10.1016/j.jaccao.2023.02.004

Ejemplares similares